Public limited company · Oslo
OBSERVE MEDICAL ASA
ActiveWholesale of pharmaceutical and medical goods (46.460)
The life line 2019–2026
Operating revenue per year, with recorded events above. As a table
Operating revenue 2025: NOK 2.9m.
Sources: the Register of Company Accounts (company accounts), fetched 15 Nov 2026; the Brønnøysund Register Centre. Each event has the colour of the section it is in.
In brief
OBSERVE MEDICAL ASA is a public limited company in Oslo, founded in 2019, in the industry wholesale of pharmaceutical and medical goods. The chief executive is Jørgen Mann Nielsen, and the chair of the board is Terje Bakken. In 2025 the company had NOK 2.9m in operating revenue and a net profit of NOK −49.1m; the group had revenue of NOK 21.1m. The largest owner is NAVAMEDIC ASA with 9.2%.
Put together by Intelligo from the sections below; each figure stands with its source where it belongs.
Overview
§ 01 Latest changes
4 changes, latest 29 Sep 2026
- Endring av revisor
- Annual accounts filed 2024 → 2025
- Godkjent årsregnskap
- SONGA CAPITAL AS in as an owner with 7.3%
Source: the Brønnøysund Register Centre and Intelligo's own observations, fetched 15 Nov 2026 · All events →
Overview
§ 02 Worth knowing
2 points
- NoteOperating loss three years running, 2023–2025
- NoteChanged auditor 29 Sep 2026
Assumed: derived by Intelligo by fixed rules, not a credit rating. How we calculate
Overview
§ 03 Key figures
Revenue NOK 2.9m in 2025
Revenue
NOK 2.9m
−26.1% from 2024
20232025
Operating profit
NOK −16.3m
−11.3% from 2024
20232025
Net profit
NOK −49.1m
+74.7% from 2024
20232025
Equity
NOK 12.3m
+54.6% from 2024
20232025
Source: the Register of Company Accounts, read 15 Nov 2026 · The full accounts →
Finances
§ 04 Where the money comes from and goes
Financial year 2025
Of every krone of operating revenue in 2025:
- Wages and social costs 296%
- Depreciation 7%
- Other operating costs 351%
Costs exceeded revenue: the operating result was NOK −16.3m.
Source: the Register of Company Accounts via areg.no, read 15 Nov 2026
Finances
§ 05 Financial health
Equity ratio 14.6%
- OBSERVE MEDICAL ASA, 2025
- Industry median, assumed: NOK 8.5m · 4.3% · 41.6% · +7.3%
Equity NOK 12.3m15% of the assets (NOK 84.2m)
Source: the Register of Company Accounts, read 15 Nov 2026. The median is derived by Intelligo from 538 companies in 46.460 Wholesale of pharmaceutical and medical goods, not stated by the source.
Finances
§ 06 Accounts
7 years, latest 2025
| NOK 1,000 | 2023–25 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Operating revenue | 2,935 | 3,974 | 2,591 | |
| Operating profit | −16,275 | −14,618 | −19,124 | |
| Profit before tax | −49,147 | −194,216 | −27,578 | |
| Net profit | −49,147 | −194,216 | −27,578 | |
| Total assets | 84,167 | 98,083 | 467,114 | |
| Equity | 12,296 | 7,952 | 355,305 | |
| Liabilities | 71,871 | 90,130 | 111,809 |
Source: the Register of Company Accounts, read 15 Nov 2026 · All 7 years →
Management and ownership
§ 07 Officers
6 officers now
- ECIT SERVICES ASAccountant
- Jørgen Mann NielsenChief executive since 2025
- Terje BakkenChair of the board since 2019
- BDO ASAuditor since 2026
- Eskild EndrerudBoard member since 2022
- Line TønnessenBoard member since 2022
Source: the Brønnøysund Register Centre, read 30 Sep 2026 · All 7 roles, former ones too →
Management and ownership
§ 08 Signature, procuration and authorisations
The board has no authorisation in force now.
Source: authorisations from the announcements of the Register of Business Enterprises, read 2 Nov 2026
Management and ownership
§ 09 Owners
173 shareholders · largest 9.2%
| Owner | Share |
|---|---|
| NAVAMEDIC ASA | 9.2% |
| R INVESTMENT COMPANY AS | 7.9% |
| SONGA CAPITAL AS | 7.3% |
| 170 others | 75.6% |
Source: the Tax Administration's Register of Shareholders as of 31 December 2025, read 31 Jul 2026 · All 173 owners →
Management and ownership
§ 10 Group
2 subsidiaries
- OBSERVE MEDICAL AS100%
- BIIM ULTRASOUND AS100%
The group 2025: operating revenue NOK 21.1m (+14.0%).
Share held. Source: the Tax Administration's shareholder register, fetched 31 Jul 2026 · The whole group →
Management and ownership
§ 11 Portfolio
None registered
No holdings registered.The shareholder register has no shares held by the company. Checked 15 Nov 2026.
Management and ownership
§ 12 Network
35 connections
- Person
- Company
4 people link OBSERVE MEDICAL ASA to 26 other companies: Eskild Endrerud 13, Terje Bakken 9, Line Tønnessen 7 and Jørgen Mann Nielsen 1.
Source: the Brønnøysund Register Centre, read 30 Sep 2026 · Explore the network →
Events and registers
§ 13 Events
78 since 2019
Events per year
20192026
Since 2019: 73 announcements, 1 register change and 3 new and 1 former owners. Most happened in 2019 and 2025.
Source: the announcements of the Brønnøysund Register Centre, the Tax Administration's Register of Shareholders, Doffin, TED and NAV, read 2 Nov 2026. Register changes are Intelligo's own observations. · All 78 events →
Events and registers
§ 14 Notices
73, latest 29 Sep 2026
- Revisor
- Godkjente årsregnskap
- Kapital
Source: The Brønnøysund Register Centre's announcements ↗, read 2 Nov 2026 · All 73 →
Events and registers
§ 15 Charges
Not fetched yet
Events and registers
§ 16 Other registers
Found in 3 of 7
- The Central Coordinating RegisterRegistered 17 Jun 2019
- VATRegistered
- The Register of Business EnterprisesRegistered 17 Jun 2019
- The Cleaning RegisterNot registered
- The Register of Staffing AgenciesNot registered
- Smiley scheme, the Norwegian Food Safety AuthorityNot registered
- The Financial Supervisory Authority's licence registerNot registered
Purpose: Selskapets virksomhet er å utvikle, produsere, markedsføre og selge medisinsk teknisk utstyr og relaterte produkter, utføre konsulenttjenester i denne sammenheng, samt å investere i relatert virksomhet.
Source: the Brønnøysund Register Centre, the Labour Inspection Authority, the Food Safety Authority and the Financial Supervisory Authority, each on its own, fetched 15 Nov 2026
Market
§ 17 Tenders
None registered
No tenders recorded.No public tenders won, lost or announced, in Doffin or TED. Checked 15 Nov 2026.
Market
§ 18 Vacancies
None registered
No vacancies.No open ads at NAV. Checked 15 Nov 2026.
Market
§ 19 Competitors
Industry code 46.460
The companies most like it:
Compare themThe selection is Intelligo's, not stated by the source: companies met in tenders and winners of tenders of the same kind, otherwise the same industry code, nearest in place and size. Source: the Brønnøysund Register Centre, Doffin and TED, fetched 15 Nov 2026 · All competitors → · Largest in the industry →
Last
§ 20 Questions and answers
6 questions
- Who is the chief executive of OBSERVE MEDICAL ASA?
Jørgen Mann Nielsen, since 2025. § 07 - Who owns OBSERVE MEDICAL ASA?
173 shareholders. The largest is NAVAMEDIC ASA with 9.2%, R INVESTMENT COMPANY AS with 7.9% and SONGA CAPITAL AS with 7.3%. § 09 - What was the revenue in 2025?
NOK 2.9m in the company and NOK 21.1m in the group. § 06 - Who is the auditor?
BDO AS, from 29 Sep 2026. § 07 - Where is OBSERVE MEDICAL ASA based?
Dronning Eufemias gate 16, 0191 Oslo. - When was OBSERVE MEDICAL ASA founded?
13 Jun 2019, registered in the Register of Business Enterprises 17 Jun 2019. § 16
The answers come from the sections linked to, with their sources.